Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1026 | 1027 | (Page 1028) | 1029 | 1030 | .... | 1118 | newer

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The global stable isotope labeling market is expected to reach USD 294.2 Million by 2022 from USD 254.6 Million in 2017, at a CAGR of 2.94%. The growth of this market is majorly driven by the increasing research activities in the pharmaceutical and biotechnology sector, growing proteomics research, and rising cancer prevalence. However, the high cost of these compounds may hinder the growth of the market to a certain extent.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-stable-isotope-labeled-compounds-market-analysis-and-forecast-to-2022-growth-opportunity-as/2996024

    The report analyzes the market on the basis of type, application, end user, and region. Based on type, the market is segmented into Carbon-13, Deuterium, Oxygen-18, Nitrogen-15, and other isotopes. The Deuterium (H-2) segment is expected to account for the largest share of the market in 2017, owing to its increased use in various research processes. By application, the market is segmented into research, clinical diagnostics, industrial, and other applications. The research segment is expected to account for the largest share of the market in 2017. Based on end user, the stable isotope labeling market is segmented into pharmaceutical and biotechnology companies, research & academic institutes, hospitals & diagnostic centers, and others. In 2017, pharmaceutical and biotechnology companies are expected to account for the largest share of the market and are also projected to grow at the highest CAGR during the forecast period.

    Request free sample @ https://www.researchcosmos.com/request/2996024

    In 2017, North America is estimated to account for the largest share of the global market, followed by Europe. Factors such as the growing pharmaceutical and biopharmaceutical industry, isotope production and distribution program fund, and the presence of a large nuclear industry in the U.S.; the growing Canadian pharmaceutical industry and rising adoption of PET imaging in Canada are supporting the growth of the North American stable isotope labelling market. This region is also expected to register the highest CAGR during the forecast period.

    In 2017, Cambridge Isotopes Laboratories, Inc. (U.S.) and Merck KGaA (Germany) dominated the global stable isotope-labeled compounds market. Some of the other players competing in the market are URENCO (U.K.), IsoSciences, LLC (U.S.), Medical Isotopes, Inc. (U.S.), Omicron Biochemicals, Inc. (U.S.), Nordion (Canada) Inc., Trace Sciences International (U.S.), Alsachim (France), Taiyo Nippon Sanso Corporation (Japan), PerkinElmer Inc. (U.S.), and Rotem Industries Israel, Ltd. (Israel).

    Check for discount @ https://www.researchcosmos.com/discount/2996024

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 01, 2018 ) The global research antibodies market (including reagents) is projected to reach USD 12.60 Billion by 2022 from USD 9.33 Billion in 2017, growing at a CAGR of 6.2% during the forecast period. Factors such as the increasing R&D activities and expenditure in the life science industry, increasing funding for proteomics research and drug discovery, and growing collaboration between industries and academic institutes are the key drivers of the market.

    The report analyzes the global research antibodies market (including reagents) by product, technology, application, end user, and region. Based on product, the market is segmented into reagents and antibodies. The reagents segment accounted for the major share of the research antibodies market (including reagents) in 2016. This can be attributed to the fact that a large number of reagents are used in various routine assays and techniques. Furthermore, based on type, the reagents market has been further segmented into media & sera, stains & dyes, fixatives, buffers, probes, solvents, enzymes, and others (controls, stabilizers, and diluents). The media & sera segment is expected to dominate the market in 2016 due to its high usage in all types of assays, culture procedures, and techniques.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-research-antibodies-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/1601727

    The antibodies market has also been segmented on the basis of type, source, and research area. Based on type, the research antibodies market is segmented into primary antibodies and secondary antibodies. In 2016, the primary antibodies is expected to dominate the market due to its high adoption in numerous types of assay formats, including western blotting, ELISA, immunoprecipitation, and IHC. These antibodies provide high specificity, sensitivity, and affinity; which further drives their high adoption. On the basis of source, the antibodies market has been segmented into mice, rabbit, and other animals (chickens, goats, rats, guinea pigs, hamsters, and sheep). The mice segment dominated the market in 2016. Based on research area, the antibodies market has been segmented into oncology, infectious diseases, immunology, neurobiology, stem cell, and others (epigenetics, toxicology, and cardiovascular diseases). The oncology segmented held the largest share of the market in 2016 due to the fact that cancer is the leading cause of deaths worldwide, which has driven the focus on its early detection and treatment. Moreover, understanding the cause and risk factors of cancer also form an important area of cancer research.

    Based on technology, the research antibodies market is segmented into western blotting, flow cytometry, ELISA, immunohistochemistry, immunofluorescence, immunoprecipitation, and others (electrophoresis, bio-imaging, and microarrays). The western blotting segment accounted for the largest share of the global research antibodies market in 2016. Its ability to quantify as little as 0.1 nanograms of protein in a sample with high specificity makes it an indispensable tool in proteomic research; this is the key factor driving market growth.

    Request free sample @ https://www.researchcosmos.com/request/1601727

    On the basis of application, the research antibodies market is segmented into proteomics, drug development, and genomics. In 2016, the proteomics segment dominated the applications market. This large share can be attributed to the high deployment of proteomic-based approaches in disease profiling, increasing government funding, rising demand of personalized & protein therapeutics, and increasing R&D expenditure.

    Based on end user, the market has been segmented into pharmaceutical & biotechnological companies, academic & research institutes, and contract research organizations. In 2016, the pharmaceutical and biotechnological companies accounted for the largest share of the research antibodies market. This can be attributed to the high uptake of research-specific antibodies in the drug discovery and development process, along with the increasing use of these research tools in the proteomics research sector.

    Geographically, the global research antibodies market is segmented into Europe, Asia-Pacific, North America, Latin America, and the Middle East & Africa. North America holds the largest share of this market. However, the Asia-Pacific region is expected to witness the highest CAGR during the forecast period of 2017 to 2022. The growth of this segment can be attributed to the growing proteomics and genomics research & increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics.

    Check for discount @ https://www.researchcosmos.com/discount/1601727

    The global research antibodies and reagent market is characterized by a large number of players. The market is highly competitive in nature and is dominated by Thermo Fisher Scientific, Inc. (U.S.), Merck Group (Germany), Abcam plc (U.K.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), GenScript (U.S.), PerkinElmer, Inc. (U.S.), Lonza (Switzerland), and BioLegend, Inc. (U.S.). Key players in the market are pursuing several organic and inorganic growth strategies such as product launches, expansions, acquisitions, and agreements to garner larger shares of the market. During 2013 to 2017, companies adopted product launches as their major growth strategy followed by acquisitions.

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 02, 2018 ) Summary:

    Mart Research Published “Global Healthcare Natural Language Processing Market” Research Report Which Provides Industry Share, Key Players, Regions and Revenue.

    Description:

    This report studies the global Healthcare Natural Language Processing market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Healthcare Natural Language Processing market by companies, region, type and end-use industry.

    Get a sample copy of Healthcare Natural Language Processing market report @ https://martresearch.com/contact/request-sample/3/1982 .

    This report focuses on the global top players, covered
    o NLP Technologies.
    o NEC Corporation
    o Apple, Inc.
    o Microsoft Corporation
    o Dolbey Systems
    o IBM Corporation
    o NetBase Solutions, Inc.
    o SAS Institute Inc.
    o Verint Systems, Inc.
    o eContext
    o Linguamatics Ltd.
    o Artificial Solutions

    Market segment by Regions/Countries, this report covers
    o United States
    o Europe
    o China
    o Japan
    o Southeast Asia
    o India

    Market segment by Type, the product can be split into
    o Machine Translation
    o Information Extraction
    o Automatic Summarization
    o Text and Voice Processing

    Market segment by Application, Healthcare Natural Language Processing (NLP) can be split into
    o Hospital
    o Clinic
    o Others

    Browse Healthcare Natural Language Processing market complete report @ https://martresearch.com/market-analysis/global-healthcare-natural-language-processing-(nlp)-market-size,-status-and-forecast-2025/3/1982 .

    The study objectives of this report are:
    o To study and forecast the market size of Healthcare Natural Language Processing in global market.
    o To analyze the global key players, SWOT analysis, value and global market share for top players.
    o To define, describe and forecast the market by type, end use and region.
    o To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
    o To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
    o To identify significant trends and factors driving or inhibiting the market growth.
    o To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    o To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    o To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    o To strategically profile the key players and comprehensively analyze their growth strategies.

    Make an Enquiry before buying Healthcare Natural Language Processing market report @ https://martresearch.com/contact/enquiry/3/1982

    In this study, the years considered to estimate the market size of Healthcare Natural Language Processing are as follows:
    o History Year: 2013-2017
    o Base Year: 2017
    o Estimated Year: 2018
    o Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Key Stakeholders:
    o Healthcare Natural Language Processing Manufacturers
    o Healthcare Natural Language Processing Distributors/Traders/Wholesalers
    o Healthcare Natural Language Processing Subcomponent Manufacturers
    o Industry Association
    o Downstream Vendors

    Available Customizations:
    With the given market data, Mart Research offers customizations according to the company's specific needs. The following customization options are available for the report:
    o Regional and country-level analysis of the Healthcare Natural Language Processing market, by end-use.
    o Detailed analysis and profiles of additional market players.

    About Us:

    We, at MART RESEARCH value your time the most as we believe that time saved is directly proportional to profits earned. Before launching ourselves into this service, we did an extensive survey to understand the challenges clients face while gaining access to authentic data reports. The need of the hour was a common platform which could showcase published reports across a wide range of sectors. To overcome this limitation, we setup a repository which is a comprehensive one-stop shop for all your report requirements. It is user friendly, easy to browse, search and acquire reports which would fulfill your generalized as well as customized business needs.



    Lisa Thorres
    +1 857-300-1122
    lisa@martresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) RNA (Ribonucleic acid) is a nucleic acid polymer wherein the carbohydrate is ribose. RNA is usually single-stranded, as DNA is transcribed by means of RNA polymerases into mRNA (messenger RNA), which is study by way of ribosome’s to generate protein (translation). Biologically lively RNAs, including transport, ribosomal and small nuclear RNA (tRNA, rRNA, snRNAs) fold into specific systems guided by means of complementary pairing among nucleotide bases.

    RNA sequencing (RNAseq) is a not unusual tool for measuring relative gene expression levels. It is a flexible approach that may be applied to stumble on and represent gene expression, mutations, gene fusions, and noncoding RNAs. Centered RNA sequencing is an especially correct approach for deciding on and sequencing unique transcripts of hobby that offer each quantitative and qualitative information. Targeted RNA sequencing is a sequencing-based gene expression profiling method that lets in the quantification of messenger RNA (mRNA) or centered non-coding RNA (ncRNA) tiers for up to three hundred Patron-defined genes in a single amplification reaction.

    View sample and decide: https://www.marketdataforecast.com/market-reports/latin-america-rna-analysis-market-4545/request-sample

    Latin America RNA analysis market was worth USD 230 million in 2016. It is anticipated to develop at a CAGR of 12% to attain USD 440 million by way of 2021. It captures 12% of the global market.

    Drivers and Restraints:

    The RNA analysis has witnessed a vast growth in the past few years particularly because of the increasing technological improvements within the subject of ‘omics’ studies and alertness of sequencing technology in RNA evaluation research. In addition, the growing authorities and private investment for research coupled with research and improvement investments by way of the biotechnology organizations are expected to rise the market. Similarly, the utility of RNA evaluation in the discipline of biomarker discovery opens new growth avenues with the growing choice of a personalized medicinal drug throughout the globe.

    But, the higher investment charges that restrict the adoption of RNA analysis products and a dearth of skilled experts are the elements hampering the growth of this market to a sure extent.

    To know more read: https://www.marketdataforecast.com/market-reports/latin-america-rna-analysis-market-4545/

    Geographic Segmentation

    Latin America RNA analysis market is geographically segmented into Mexico, Brazil, Chile, Argentina, and others. In the forecast period, emerging countries of Latin America are expected to form new sales-generating pockets for the marketplace gamers. Monetary tendencies and growing authorities funding to aid new product traits are the essential factors fuelling the increase of marketplace in those regions.

    Get your customized report: https://www.marketdataforecast.com/market-reports/latin-america-rna-analysis-market-4545/customize-report

    The main players of the market include Illumina Inc. (U.S.), Qiagen N.V. (Germany), Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), and Thermofisher Scientific Inc. (U.S.).



    Scope of the report

    The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

    The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

    What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

    Contact Info:
    Name: Mr. Abhishek Shukla
    Email: abhishek@marketdataforecast.com
    Organization: MarketDataForecast™
    Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
    Phone: +1-888-702-9626


    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The global stem cell therapy market is expected to reach USD 145.8 Million by 2021, growing at a CAGR of 11.0% during the forecast period. Factors such as the growing awareness related to the therapeutic potency of stem cells in disease management, ongoing development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research and product development, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are driving the growth of the global market. However, factors such as unclear regulatory guidelines related to the development & commercialization of stem cell therapy products and socio-ethical issues related to the adoption of ESCs in disease treatment are restraining the growth of this market. In addition to this, technical limitations related to production scale-up pose a key challenge for players operating in this market.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-stem-cell-therapy-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/3606048

    On the basis of type, the global market is divided into two major categories, namely, allogeneic stem cell therapy and autologous stem cell therapy. On the basis of application, the allogeneic stem cell therapy market is further divided into musculoskeletal disorders, wounds and injuries, surgeries, acute Graft-Versus-Host Disease (aGVHD), and other applications. On the basis of application, the autologous stem cell therapy market is categorized into wounds and injuries, cardiovascular diseases, gastrointestinal diseases, and other applications. The allogenic stem cell therapy segment is expected to grow at the highest CAGR during the forecast period, owing to the rising commercialization of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, and growing number of clinical trials related to allogeneic stem cell therapies.

    Request free sample @ https://www.researchcosmos.com/request/3606048

    On the basis of region, this market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global market is expected to be dominated by North America. Also, this region is expected to be the fastest-growing region during the forecast period. Factors such as growing awareness related to the therapeutic potency of stem cells, increasing number of clinical trials for stem cell-based products, and increasing public-private funding & research grants are driving the growth of this market in the North American region.

    New product launches and approvals are the key growth strategies adopted by major players to strengthen their positions in the global market. Moreover, strategies such as expansions as well as partnerships and agreements were also adopted by several market players to expand their R&D capabilities and geographic presence in the global market.

    As of 2015, Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), RTI Surgical, Inc. (U.S.), and AlloSource (U.S.) were some of the key players operating in the global market.

    Check for discount @ https://www.researchcosmos.com/discount/3606048

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The sterility testing market is expected to reach USD 941.0 Million by 2021 from USD 528.0 Million in 2016, at a CAGR of 12.3%. The global market is segmented on the basis of product, test, and application. Sterility testing is an important and mandatory step in the manufacturing process to remove or inactivate potential bacterial contaminants. Growth in the pharmaceutical and biotechnology industries, increase in the number of new drug launches, and increasing R&D in life science research are the key factors driving the growth of this market.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-sterility-testing-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/9623725

    On the basis of product, the market is segmented into kits and reagents, instruments, and services. The kits and reagents segment is expected to account for the largest share of the market. The large share of the kits and reagents segment can be attributed to the requirement of the repeat purchase of these products, coupled with the increasing preference for kit-based testing.

    On the basis of test, the market is segmented into membrane filtration, direct inoculation, and other sterility tests. In 2016, the membrane filtration segment accounted for the largest share. The large share of this segment can primarily be attributed to rapid growth in the pharmaceutical and biotechnology end-use industry.

    Request free sample @ https://www.researchcosmos.com/request/9623725

    On the basis of application, the market is segmented into pharmaceutical and biological manufacturing, medical devices manufacturing, and others applications. In 2016, the pharmaceutical and biological manufacturing segment accounted for the largest share primarily due to the rapid growth in the pharma and biotech industries.

    Based on region, the global sterility testing market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, the Asian market will witness the highest growth during the forecast period, primarily due to the increasing expenditure on life science research in the region and growing trend of pharmaceutical outsourcing to Asian countries like India and China.

    The major players in the market include Merck KGaA (Germany), Charles River Laboratories International, Inc. (U.S.), bioMérieux SA (France), SGS S.A. (Switzerland), Sartorius AG (Germany), WuXi AppTec (China), and Thermo Fisher Scientific, Inc. (U.S.).

    Check for discount @ https://www.researchcosmos.com/discount/9623725

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The sterilization monitoring market is expected to reach USD 631.0 Million by 2022 from USD 439.5 million in 2017, at a CAGR of 7.5% between 2017 and 2022. Factors such as rising incidence of hospital-acquired infections, increasing number of surgical procedures coupled with the rising geriatric population and chronic disease incidence, technological advancements in sterilization monitoring products, and rising focus on food sterilization are the major factors driving the growth of this market. However, factors such as lack of awareness on sterilization monitoring and dearth of skilled professionals are hampering the growth of this market.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-sterilization-monitoring-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/7888326

    On the basis of technology, the global sterilization monitoring market is segmented into biological monitoring, chemical monitoring, and mechanical monitoring. The chemical indicators segment is expected to grow at the highest CAGR owing to its advantage to deliver immediate valuable information about specific parameters of the sterilization process such as time, temperature, and steam quality.

    On the basis of product, the biological indicators market is categorized into self-contained vials, spore strips, spore ampoules, and spore suspensions. The self-contained vials segment is expected to grow at the highest CAGR during the forecast period owing to faster results, shorter processing time, ease of use, and reduced incubation period. Furthermore, the chemical indicators market is categorized into internal chemical indicators and external chemical indicators. The internal chemical indicators segment are categorized as single-parameter indicators (class 3), multi-parameter indicators (class 4), integrating indicators (class 5), and emulating indicators (class 6). The integrating indicators segment held the largest share of the global internal chemical indicators market.

    On the basis of method of Sterilization, the global sterilization monitoring market is segmented into steam sterilization, ethylene oxide sterilization, hydrogen peroxide sterilization, and formaldehyde sterilization. The ethylene oxide (EtO) sterilization segment accounted for the second-largest share of the global market for sterilization monitoring in 2016. The growth of this market can be attributed to the various advantages offered by the method such as low temperature, high efficiency (destroys microorganisms, including resistant spores), large sterilizing volume/chamber capacity, and non-corrosive to plastic, metal, and rubber materials.

    Request free sample @ https://www.researchcosmos.com/request/7888326

    Based on process, the market is categorized into pack monitoring, load monitoring, equipment/process monitoring, and exposure monitoring. The load monitoring segment accounted for the second-largest share of the global sterilization monitoring market in 2016. Load monitoring enables the user to make decisions and take actions prior to surgery, which reduces the risks and costs associated with recalls and surgical infections. Moreover, the use of biological indicators in load monitoring reduces the quarantine time by 88% providing BI results in 3 hours. These factors are driving the growth of this market during the forecast period.

    On the basis of end user, the market is segmented into hospitals; pharmaceutical, biotechnology, and medical device companies; research & academic institutes; food & beverage industry; and other end users. The pharmaceutical, biotechnology, and medical device companies segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to factors such as increasing number of pharmaceutical and biotechnology companies in the Asia-Pacific region, rising need to ensure sterility, and the practice of enhancing aseptic manufacture sterility assurance level (SAL) of pharmaceuticals.

    This report covers the sterilization monitoring market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the global market in 2017, followed by Europe and Asia-Pacific. The Asia-Pacific market is expected to register the highest CAGR during the forecast period. The high growth of this regional segment can be attributed to growth in per capita income, increasing number of hospitals, growth in geriatric population, increase in the number of surgical procedures, and growth in the pharmaceutical and medical devices industry.

    The major players in the global market for sterilization monitoring include 3M Company (U.S.), Getinge Group (Sweden), Cantel Medical Corp. (U.S.), STERIS plc (U.S.), Cardinal Health, Inc. (U.S.), Mesa Laboratories, Inc. (U.S.), Propper Manufacturing Co. Inc. (U.S.), PMS Healthcare Technologies (Turkey), Hu-Friedy Mfg. Co., LLC (U.S.), and gke-GmbH (Germany).

    Check for discount @ https://www.researchcosmos.com/discount/7888326

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The global sterilization services market is projected to reach USD 3.31 Billion by 2022 at a CAGR of 6.7% during the forecast period. The growth of the market can be attributed to the increasing focus on outsourcing of sterilization processes among pharmaceutical companies, hospitals, and medical device manufacturers; increasing prevalence of hospital-acquired infections; growth in the number of surgical procedures; and rising focus on food sterilization and disinfection. Also, factors such as the growth in the medical devices market, emerging markets, and increasing demand for e-beam sterilization are further providing growth opportunities for the global market during the forecast period.

    The sterilization services market in this report is segmented on the basis of sterilization method, type, mode of delivery, and end user. This report also provides market information on major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-sterilization-services-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/7132333

    Based on sterilization method, the ethylene oxide segment dominated the sterilization services market in 2016. The growth can be attributed to its extensive usage in various applications, including medical device sterilization, food testing, pharmaceutical sterilization, and sterilization and disinfection in the life sciences industry. Moreover, advantages such as the penetration capabilities, high material compatibility, and low costs associated with the use of this sterilization method are also expected to drive market growth.

    On the basis of type, the sterilization services market is segmented into contract sterilization services and sterilization validation services. The contract sterilization services segment is expected to register the highest CAGR during the forecast period. This is attributed to the growing preference for contract sterilization by medical device companies as well as the increasing outsourcing of sterile processing by hospitals to specialized third-party vendors in order to reduce in-house costs related to sterilization.

    Based on mode of delivery, the sterilization services market is segmented into offsite sterilization services and onsite sterilization services. In 2016, offsite market accounted for the largest share of the global market. The limited availability of space in in-house sterile processing departments, better efficiency of contract sterilization process than in-house sterilization, greater output with less financial risk, and the cost reduction benefits offered by offsite sterilization services are the key factors supporting its growth.

    Request free sample @ https://www.researchcosmos.com/request/7132333

    On the basis of end user, the global sterilization services market is segmented into medical device companies, hospitals and clinics, pharmaceutical & biotechnology industry, and other end users. In 2016, the medical device companies segment accounted for the largest share of the global market. The growth in this end-user segment can be attributed to factors such as the increasing number of medical device companies in Asia Pacific, rising need to ensure sterility, and increasing use of single-use products.

    In 2016, North America dominated the global sterilization services market. The growth in this market can mainly be attributed to the growing outsourcing of sterilization services by medical devices companies and hospitals, rising instance of HAIs, growing regulations for the use of sterilized medical devices, increasing number of surgeries performed in the US, and growing intensity of industry competitiveness.

    The Asia Pacific region is expected to grow at the highest CAGR during the forecast period. Factors such as growing economies of China and India, increasing incidence of nosocomial infections, expanding medical device and pharmaceutical industry, and improved healthcare infrastructure in Asian countries are driving the growth of the sterilization services market. In addition, growing medical tourism in the region, especially for cardiovascular, orthopedics, oncology, and fertility treatments, is expected to increase the focus on the need for proper sterilization services in healthcare setups.

    Factors such as the carcinogenic nature of ethylene oxide and difficulty in the sterilization of advanced medical instruments are likely to hinder the growth of the sterilization services market to some extent.

    Check for discount @ https://www.researchcosmos.com/discount/7132333

    The players in the sterilization services market include STERIS (UK), Cantel Medical (US), Cretex Companies (US), E-BEAM Services (US), Medistri (Switzerland), Beta-Gamma-Service (Germany), Sterigenics International (US), COSMED Group (US), Life Science Outsourcing (US), Noxilizer (US), Centurion Medical Products (US), Johnson & Johnson (US), and Stryker (US).

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The global ostomy care market is projected to reach USD 2.99 Billion by 2022 from USD 2.40 Billion in 2017, at a CAGR of 4.5% during the forecast period. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of the stoma care market.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-stoma-ostomy-care-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/6786288

    This report broadly segments the ostomy care market into product and end user. On the basis of product, the market is categorized into ostomy care bags and ostomy care accessories. The bags segment is further categorized into surgery type, system type, and usability. On the basis of surgery type, ostomy bags are segmented into – ileostomy, colostomy, and urostomy. On the basis of system type, the market is classified into one-piece systems, two-piece systems, and skin barrier. On the basis of usability, bags are segmented into drainable and closed-end bags. While accessories are further segmented into pastes & powders, creams, deodorants, cleansers, and other accessories.

    In 2017, the ostomy care bags segment is expected to account for the largest share of the market.

    Based on end user, the stoma care market is segmented into home care and hospitals & ambulatory surgical centers. Home care settings are expected to account for a larger share of the global market in 2017. The large share of this end-user segment can primarily be attributed to the rising incidence of risk factors such as Inflammatory Bowel Disease (Crohn’s disease and Ulcerative Colitis) and colorectal cancer.

    Request free sample @ https://www.researchcosmos.com/request/6786288

    On the basis of region, ostomy care market is segmented into North America, Europe, Asia, and the rest of the world. Among these regions, Europe is estimated to hold the largest market share in 2017 owing to the fact that European countries have a higher prevalence of IBD which is results in a higher number of ostomy surgeries. The unfavorable reimbursement scenarios in most of developing countries, and discomfort and other issues associated with the use of ostomy bags are expected to restrain the growth of this market.

    The major players of the stoma care market are ConvaTec (UK), Coloplast (Denmark), Hollister Incorporated (US), B. Braun (Germany), Alcare (Japan), Nu-Hope (US), Marlen (US), Welland Medical (UK), BAO-Health (China), Flexicare Medical (UK), Cymed (US), Schena Ostomy (US), Perma-Type (US), 3M (US), and Smith & Nephew (UK).

    Check for discount @ https://www.researchcosmos.com/discount/6786288

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) Surface disinfectants are chemical formulations that eliminate microorganisms from surfaces or significantly decrease the possibility of their transfer through hand contact between surfaces. These include bedside tables, chairs, walls, floors, and medical equipment (clinical contact surfaces). The global surface disinfectant market is expected to reach USD 789.1 Million by 2022 from USD 529.6 Million in 2017, at a CAGR of 8.3%. Increasing number of surgical procedures, rising geriatric population, and subsequent growth in the prevalence of chronic diseases are the major driving factors for this market.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-surface-disinfectant-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/9276491

    The surface disinfectants market is segmented on the basis of type, formulation, application, and end user. On the basis of type, the market is segmented into quaternary ammonium compounds, chlorhexidine gluconate, phenolic compounds, alcohols, aldehydes, and other surface disinfectants. The quaternary ammonium compounds segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to widespread availability and large consumption of surface disinfectants in hospitals.

    Based on formulation, the surface disinfectant market is segmented into liquids, wipes, and sprays. In 2017, the liquids segment accounted for the largest share of the market. Factors such as the increasing demand for the disinfection of hospital areas and the wide adaptability of these formulations are expected to drive the growth of this market segment.

    Request free sample @ https://www.researchcosmos.com/request/9276491

    By region, the surface disinfectants market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, however, the Asian region is expected to witness the highest growth during the forecast period. The presence of emerging economies like China and India; large population; growth in the number of hospitals, and increasing awareness about infection control in the region are some of the key factors driving the high growth of this regional segment.

    3M Company (U.S.), Cantel Medical Corporation (U.S.), Johnson & Johnson (U.S.), Procter & Gamble (U.S.), Reckitt Benckiser Group plc. (U.K.), The Clorox Company (U.S.), Sealed Air Corporation (U.S.). Steris Corporation (U.S.), and Ecolab (U.S.) are the top players in this market. These companies have a broad product portfolio with comprehensive features and have a strong geographical presence.

    Check for discount @ https://www.researchcosmos.com/discount/9276491

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The surgical drains market is expected to reach USD 2.18 Billion by 2022 from USD 1.82 Billion in 2017, growing at a CAGR of 3.7%. The growth of this market is mainly driven by the growing geriatric population, increasing number of surgical procedures, and rising awareness programs globally.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-surgical-drains-wound-drainage-market-analysis-and-forecast-to-2022-growth-opportunity-asse/8030430

    This report segments the wound drainage market into product, type, application, end user, and region. Based on product, the market is segmented into accessories and surgical drainage systems. The surgical drainage systems segment is expected grow at the highest CAGR during the forecast period. The high growth in this segment is attributed to the growing volume of high-risk surgical procedures and the benefits associated with surgical drainage systems, such as accurate measurement of drainage, lowering bacterial levels, and effective in closing wound edges.

    Based on application, the surgical drains market is segmented into general surgery, cardiac and thoracic surgery, orthopedic surgery, obstetrics/gynecology surgery, and other surgeries. The cardiac and thoracic surgery segment is expected to register the highest CAGR during the forecast period.

    Request free sample @ https://www.researchcosmos.com/request/8030430

    In 2017, North America is expected to dominate the market, followed by Europe. The increasing incidence of chronic wounds and surgical site infections, growing number of surgical procedures, rising geriatric population, and higher adoption & awareness of advanced surgical & wound care products are the key factors driving the growth of the surgical drains market in North America.

    Asia is expected to grow at the highest CAGR during the forecast period. The high demand for advanced wound care products in several Asian countries, rising geriatric population, increasing number of surgical procedures, rising prevalence of chronic as well as diabetic wounds, and focus of major players on enhancing their presence in this region are some of the key factors driving the growth of the surgical drains market in Asia.

    The risks associated with the use of surgical drains may limit market growth to a certain extent in the coming years. The wound drainage market is highly competitive with several big and small players. Prominent players in the global market include B. Braun (Germany), Cardinal Health (US), ConvaTec (UK), C.R. Bard (US), Redax (Italy), Ethicon (US), Stryker (US), Romsons (India), Medtronic (Ireland), Medline Industries (US), Cook Medical (US), Poly Medicure (India), Zimmer Biomet (US), Global Medikit (India), and Degania Silicone (Israel).

    Check for discount @ https://www.researchcosmos.com/discount/8030430

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The global surgical imaging market is projected to reach USD 1.63 Billion by 2022 from USD 1.25 Billion in 2017, at a CAGR of 5.5% during the forecast period. The growth of this market is majorly driven by factors such as technological advancements in C-arms, increasing demand for minimally invasive procedures, rising geriatric population, and growing chronic disease prevalence.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-surgical-imaging-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/4750329

    In surgical imaging report, the market is segmented on the basis of technology, application, and region. On the basis of technology, the global market is segmented into image intensifier C-arms and Flat Panel Detector C-arms (FPD C-arms). The FPD C-arms segment is expected to register the highest CAGR during the forecast period. The high growth in this segment can be attributed to the increasing demand for minimally invasive procedures and the advantages offered by FPD C-arms such as better image quality and lower radiation exposure.

    Based on application, the market is segmented into orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other applications (urologic surgeries, endobronchial and thoracic surgeries, and maxillofacial surgeries). The orthopedic and trauma surgeries segment is expected to account for the largest share and register the highest CAGR during the forecast period.

    Request free sample @ https://www.researchcosmos.com/request/4750329

    The geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this region can be attributed to a rising number of overuse sports injuries, and rising prevalence of CVD, along with the increasing number of cardiac arrest cases, and increase in the number of minimally invasive procedures performed in Canada.

    The high cost of C-arms is likely to restrain market growth. In addition to the huge purchases cost, these equipment have several other direct expenses for printers and DICOM boxes, which results in an overall increase in the total cost of ownership. Due to the requirement of significant capital expenditure, many small and medium-sized institutions find it hard to purchase C-arms.

    GE Healthcare (US), Koninklijke Philips (Netherlands), Siemens (Germany), and Ziehm Imaging (Germany) are the key players in the surgical imaging market. Other players involved in this market are Hologic (US), Shimadzu Corporation (Japan), OrthoScan (US), Medtronic (US), Toshiba Medical Systems Corporation (Japan), GENORAY (South Korea), Eurocolumbus (Italy), and Allengers Medical Systems (India).

    Check for discount @ https://www.researchcosmos.com/discount/4750329

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The global surgical lasers market is projected to reach USD 2.37 Billion by 2021 from USD 1.85 Billion in 2016; growing at a CAGR of 5.1% during 2016-2021. The rising demand for surgical lasers can be attributed to the growing prevalence of chronic diseases, technological advancements, increasing incidence and prevalence of targeted diseases, and high prevalence of ophthalmic disorders. In addition, growing preference for minimally invasive surgeries among patients and healthcare professionals is supporting the growth of the market.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-surgical-lasers-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/7167927

    On the basis of type, the market is categorized into five segments, namely, carbon dioxide (CO2) lasers, argon lasers, Nd:YAG lasers, diode lasers, and other surgical lasers (fiber lasers, dye lasers, Er:YAG lasers, and excimer lasers). The CO2 lasers segment is at the highest CAGR in the market due to the widespread availability of innovative CO2-based surgical lasers and ongoing technological advancements in cosmetic laser treatment.

    By procedure type, the market is segmented into open surgery, laparoscopic surgery, and percutaneous surgery. The laparoscopic surgery segment is expected to dominate the market. This growth can be attributed to the procedural benefits of laparoscopic procedures, growing patient awareness, and market demand for less-invasive disease therapies.

    Based application, the market is segmented into ophthalmology, dentistry, dermatology, cardiology, gynecology, urology, oncology, and other applications (liposuction, ENT, and GIT). The urology segment is expected to be the fastest-growing surgical laser application in the market. Growth in this application segment is mainly due to the rising prevalence of urological disorders (such as kidney stones, renal cancer, and prostate enlargement), growing patient preference for minimally invasive urological surgeries, and ongoing technological advancements in surgical laser products.

    Request free sample @ https://www.researchcosmos.com/request/7167927

    On the basis of region, the market is segmented into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is estimated to dominate the global surgical lasers market. Factors such as the use of novel surgical technologies among healthcare professionals (owing to the growing number of clinical trials and significant medical reimbursement available in the U.S. for laser-assisted surgical procedures) and a large number of cosmetic laser equipment manufacturers in the region enabled the growth of this market. The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. The growth opportunities in the Asia-Pacific region can be attributed to the increasing aging population, rising prevalence of targeted diseases such as cardiovascular diseases and cancer, and a huge patient population.

    Product launches, product enhancements, and approvals were the primary growth strategies adopted by major players to expand their product portfolio in the global market. Several market players also adopted strategies such as acquisition and agreements to expand their presence and increase their visibility in the market. As of 2015, Lumenis (Israel), Cynosure, Inc. (U.S.), Alma Lasers (Israel), Abbott Laboratories, Inc., (U.S.), Boston Scientific Corporation (U.S.) IPG Photonics Corporation (U.S.), Spectranetics Corporation (U.S.), Biolitec AG (Austria), Fotona d.o.o. (Slovenia), and BISON MEDICAL Co., Ltd. (South Korea) were some of the key players operating in the global surgical lasers market.

    Check for discount @ https://www.researchcosmos.com/discount/7167927

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The surgical sealants market is expected to witness a significant growth in the coming years. Factors such as the growing need to control blood loss in patients during surgeries, growth in the number of surgeries, rising geriatric population coupled with the increasing prevalence of chronic disorders, and the increasing uptake of technologically advanced products owing to the FDA and CE Mark approvals are driving the growth of this market. The global surgical adhesives market is projected to reach USD 2.96 Billion by 2021 from USD 1.87 Billion in 2016, at a CAGR of 9.6% from 2016 to 2021. However, lack of reimbursements and high costs associated with clinical data requirements for these products are restraining the growth of this market to a certain extent.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-surgical-sealants-and-adhesives-market-analysis-and-forecast-to-2022-growth-opportunity-ass/3385743

    Lack of reimbursements, extensive clinical data requirements for product approvals, and high cost of these products may hinder the growth of this market to a certain extent during the forecast period. Emerging markets such as China, India, and Brazil offer significant opportunities for the growth of the market. However, relatively lower disposable income and lack of awareness in these regions may negatively impact the market growth.

    The report analyzes the surgical sealants market by product, indication, application, and region. On the basis of product, the market is segmented into natural/biological sealants and adhesives and synthetic & semi-synthetic sealants and adhesives. The natural/biological sealants and adhesives segment is further divided into type and origin. On the basis of type, the natural/biological sealants segment is categorized into polypeptide/protein-based and polysaccharide-based sealants and adhesives. On the basis of origin, the natural/biological sealants and adhesives segment is divided into human blood and animal-based adhesives. Moreover, the polypeptide/protein-based sealants consist of fibrin, gelatin, collagen, and albumin-based adhesives, while the polysaccharide-based sealants comprise of chitosan-based and other polysaccharide-based adhesives. The synthetic and semi-synthetic sealants and adhesives market is segmented into cyanoacrylates, polyethylene glycol hydrogels, urethane-based adhesives, and other synthetic adhesives. On the basis of indication, the market is segmented into surgical hemostasis, tissue sealing, and tissue engineering. Based on application, the market is segmented into CNS, general, cardiovascular, orthopedic, cosmetic, urological, pulmonary, ophthalmic surgeries, and other applications.

    Request free sample @ https://www.researchcosmos.com/request/3385743

    In 2015, North America dominated the surgical sealants market followed by Europe, Asia-Pacific, and the Rest of the World. The major factors responsible for driving the growth of the market are the presence of many large hospitals and increasing number of surgical procedures being performed annually, a large number of major global players are based in the North American region, rising geriatric population and the growing prevalence of lifestyle diseases such as obesity and CVDs in the region. On the other hand, the Asia-Pacific region is expected to witness the highest growth rate during the forecast period. This can be mainly attributed to the increasing investments by major players in these regions, rising health awareness, growing per capita income, increasing medical tourism, the presence of less stringent regulations, and growing demand for quality healthcare.

    The global market is characterized by the presence of a large number of players. Amidst intense market competition, major players are continuously focusing on achieving higher market shares through gaining regulatory approvals and acquisitions in the market. The global surgical adhesives market is consolidated in nature and is dominated by Baxter International, Inc. (U.S.), Johnson & Johnson (Ethicon, Inc.; U.S.), CryoLife, Inc. (U.S.), C. R. Bard, Inc. (U.S.). Other players include Medtronic plc (U.S.), Sanofi Group (France), B. Braun Melsungen AG (Germany), Cohera Medical, Inc. (U.S.), Ocular Therapuetix, Inc. (U.S.), Vivostat A/S (Denmark), and Sealantis, Ltd. (Israel).

    Check for discount @ https://www.researchcosmos.com/discount/3385743

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The global surgical staplers market is expected to reach USD 4.78 Billion by 2022 from USD 3.38 Billion in 2017, at a CAGR of 7.2%. A number of factors such as increasing number of surgical procedures across the globe, growing preference for minimally invasive surgeries, technological advancements, and increasing preference for surgical staplers over sutures are expected to drive the growth of the market. On the other hand, high cost of devices and availability of alternative wound care techniques may hinder the growth of the market in the coming years.

    This report segments the market into product, type, application, end user, and regions.

    Explore More Information about report @ https://www.researchcosmos.com/reports/global-surgical-staplers-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/1268146

    On the basis of product, the market is segmented into manual surgical staplers and powered surgical staplers. In 2017, the manual surgical staplers are expected to account for the largest share of the market. Powered surgical staplers are expected to register the highest CAGR during the forecast period. The growth of this segment is attributed to the wide range of benefits associated with powered staplers, such as ease of use, minimal risk of complications like blood loss/leakage, shorter operating time, and reduced hospital costs as compared to manual staplers.

    The global surgical staplers market, by type is segmented into disposable surgical staplers and reusable surgical staplers. In 2017, disposable surgical staplers are expected to account for the largest share of the market. There are various advantages associated with these devices including reduced risk of surgical site infections (SSIs) and time efficiency owing to pre-sterilization of devices.

    Based on the application, the market is segmented into abdominal & pelvic surgery, general surgery, cardiac and thoracic surgery, orthopedic surgery, and other surgical applications. In 2017, abdominal & pelvic surgery is expected to account for the largest share of the market. The large share of this segment can primarily be attributed to the increasing prevalence of obesity, growing health consciousness across the globe, increasing purchasing power, and growth in the number of bariatric or weight loss surgeries across the globe.

    Request free sample @ https://www.researchcosmos.com/request/1268146

    By end user, the market is segmented into hospitals and ambulatory surgical centers (ASCs) & clinics. In 2017, the hospitals segment is expected to account for the largest share of the market. Rapidly increasing patient volume and the subsequent increase in the number of complex surgeries, easy accessibility to multiple specialty treatments in a single facility, and favorable reimbursements are the major factors driving the growth of this end-user segment.

    The market is dominated by North America, followed by Europe. North America dominated the market in 2017 and Asia-Pacific is poised to register the highest CAGR during the forecast period. The dominance of North America is attributed to factors such as the growing geriatric population, increasing incidence of diseases (leading to an increase in the number of surgeries for corrective and preventive treatments), increasing preference for bariatric and cosmetic surgeries, availability of technologically advanced products and their higher adoption rate among surgeons and patients, presence of leading surgical stapler manufactures in the region, and higher public & private spending as a percentage of GDP (resulting in better healthcare facilities and infrastructure).

    The high cost of these devices as compared to their traditional alternatives is one of the restraining factors for the growth of this market accompanied with availability of alternative wound care techniques such as fibrin sealants and surgical sealants and other alternatives, which does not require staple removals resulting in reduced inflammation and scaring.

    Check for discount @ https://www.researchcosmos.com/discount/1268146

    The global surgical staplers market is duopolistic in nature with two major players Ethicon Inc. (U.S.) and Medtronic plc (Ireland). The market also includes players such as, CONMED Corporation (U.S.), Smith & Nephew (U.K.), Purple Surgical Inc. (U.K.), Intuitive Surgical Inc. (U.S.), Welfare Medical Ltd. (U.K.), Reach Surgical Inc. (China), Meril Life Science Pvt. Ltd. (India), Grena Ltd. (U.K.), B. Braun Melsungen AG (Germany), Dextera Surgical Inc. (U.S.), Frankenman International (China), and Becton, Dickinson and Company (U.S.).

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The Global Cardiac Surgery Devices Market was worth USD 1.88 billion in 2017 and estimated to be growing at a CAGR of 3.15%, to reach USD 2.2 billion by 2022. Cardiovascular surgery can be defined as the process which is performed to resolve the defects of heart tissue like replacing the diseased heart valves if they are blocked, replacement of heart tissues in case of damage and for grafting.

    Browse full report @ https://marketdataforecast.com/market-reports/cardiac-surgery-devices-market-6769/

    Among the many types of heart surgery include open heart surgery, modern beating heart surgery, heart transplant, coronary artery bypass surgery and minimally invasive surgeries. In an open heart surgery, the heart of a patient is cut open and a surgery is performed on its internal structures. In a modern heart beating surgery, the heart continues to beat but it is stabilised to provide for a still working area. Heart transplant involves inserting a heart of one person into another person. Coronary artery bypass surgery involves creating an alternative path in order to deliver blood to heart and body.

    Get free sample report @ https://marketdataforecast.com/market-reports/cardiac-surgery-devices-market-6769/request-sample

    The driving factors of global Cardiac Surgery Devices market are growth in prevalence and incidence of heart related diseases. Also, the growth in healthcare insurance and healthcare expenditure are expected to propel the market growth during the forecast period. However, the market is constrained due to factors such as and lack of awareness among the population and shortage of experienced healthcare professionals.

    Buy now @ https://marketdataforecast.com/cart/buy-now/cardiac-surgery-devices-market-6769/

    The global Cardiac Surgery Devices market is segmented based on product type into Cardiopulmonary Bypass Equipment, Beating Heart Surgery Systems, Perfusion Disposables and Cardiac Ablation Devices. By application, the market is categorised into Cardiac Arrhythmia, Coronary Heart Disease, Congenital Heart Defects, Congestive Heart Failure and other applications. By age group, the market is divided into New-born (0-30 days), Infant (31 days-1 year), Children (1-18 years) and Adult (18+ years). In the total market, perfusion disposables has the largest market share and is also expected to have the highest growth rate.

    The Global Cardiac Surgery Devices market is divided based on geography into North America, Latin America, Asia-Pacific, Middle East and Africa and Europe. North America has the leading market for Cardiac Surgery Devices in the world, which is followed by Europe and Asia Pacific regions. Asia Pacific region is expected to have the fastest growth rate during the forecast period, owing to huge patient base and rising disposable incomes.

    Some of the major players in the market are Trinity Biotech, Abiomed, Inc., Cardinal Health, C. R. Bard, Inc., MedWaves Incorporated, CyberHeart Incorporated and Transmedics, Inc. among others.

    About Market Data Forecast™

    Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions


    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The APAC body composition analyzers market is projected to reach USD 218.26 million by 2024 from USD 114.81 million in 2016, growing at the highest CAGR of 8.5%.

    Get More information regarding this report @ https://www.researchcosmos.com/reports/apac-body-composition-analysers-market-analysis-industry-outlook-and-forecast-2017-to-2024/1864967301

    APAC Body Composition Analysers Market Segmentation:
    By Type: BIO IMPEDANCE ANALYZERS (BIA), SKINFOLD CALIPER, DUAL ENERGY X-RAY ABSORPTIOMETRY (DEXA) and AIR DISPLACEMENT PLETHYSMOGRAPHY (ADP)
    By End User: Hospitals and Clinics, Corporate Settings, Health Clubs and Others
    By Country: Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia and Philippines
    Key Companies Profiled in the report: Cosmed, GE Healthcare, Omron Healthcare, SECA, Tanita, Hologic Inc., Inbody Co Ltd., Selvas Healthcare, Beurer Gmbh, Bodystat, RJL SYSTEMS, INC., Laica Spa, Maltron International Ltd

    Request For Sample @ https://www.researchcosmos.com/request/1864967301

    The APAC body composition analyzers market is segmented on the basis of product type, end-users and region.

    The 5 types of products are Bio impedance Analyzers (BIA), Dual-Energy X-Ray Absorptiometry (DEXA), Skinfold Calipers, Air Displacement Plethysmography (ADP), and others (Hydrostatic Weighing (HwD), Ultrasound Body Composition).

    The major end-users of the market are Health Clubs, Hospitals and Clinics, Corporate Settings, and others (Medical Research, Universities).

    Make an Inquiry before buying @ https://www.researchcosmos.com/inquire/1864967301

    About Us:
    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) APAC hemostats market is expected to reach USD 595.1 million by 2024, from USD 327.6 million in 2016 growing at a CAGR of 7.8% in the forecast period 2017 to 2024.

    Get More information regarding this report @ https://www.researchcosmos.com/reports/apac-hemostats-market-analysis-industry-outlook-and-forecast-2017-to-2024/665208151

    APAC Hemostats Market Segmentation:
    By Type: THROMBIN BASED HEMOSTATS, COMBINATION AGENT HEMOSTATS, OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS, GELATIN BASED HEMOSTATS and COLLAGEN BASED HEMOSTATS
    By Application: WOUND CLOSURE and SURGICAL HEMOSTATS
    By End User: Hospitals, Ambulatory Centers, Community Healthcare and Clinics
    By Country: Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia and Philippines
    Key Companies Profiled in the report: Ethicon US, Pfizer, C.R.Bard, Baxter, Vascular Solutions, 3-D Matrix Ltd, Resorba Medical, Anika Therapeutics, Biom’Up, Cryolife, EquiMedical, Medtrade Products Limited, SMI

    Request For Sample @ https://www.researchcosmos.com/request/665208151

    The APAC hemostats market is segmented on the basis of type, application, distribution channel, and end user.

    The APAC hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats.

    On the basis of application, the market is segmented into surgery and wound closure.

    On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics.

    Make an Inquiry before buying @ https://www.researchcosmos.com/inquire/665208151

    About Us:
    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The APAC injectable drug delivery market is projected to reach USD 143,089.37 million by 2024, from USD 56,198.43 million in 2016 growing at a CAGR of 12.4% in the forecast period 2017 to 2024.

    Get More information regarding this report @ https://www.researchcosmos.com/reports/apac-injectabale-drug-delivery-market-analysis-industry-outlook-and-forecast-2017-to-2024/1955049110

    APAC Injectable Drug Delivery Market Segmentation:
    By Type: HORMONAL DISORDERS, ONCOLOGY AND ORPHAN DISEASE
    By Country: Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia and Philippines
    Key Companies Profiled in the report: Baxter International, Becton Dickinson and Company, Gerresheimer AG, Pfizer Inc., Schott AG, Alkermes Plc., Eli Lilly and Company

    Request For Sample @ https://www.researchcosmos.com/request/1955049110

    The APAC injectable drug delivery market is segmented on the basis of type, product type, application, usage pattern, mode of administration, end user, distribution channel, and geography.

    The APAC injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices.

    The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.

    Make an Inquiry before buying @ https://www.researchcosmos.com/inquire/1955049110

    About Us:
    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 03, 2018 ) The APAC IUCD devices market is projected to reach USD 2,533.9 million by 2024, from USD 2,161.5 million in 2016 growing at a CAGR of 2.0% in the forecast period 2017 to 2024.

    Get More information regarding this report @ https://www.researchcosmos.com/reports/apac-iucd-devices-market-analysis-industry-outlook-and-forecast-2017-to-2024/843566907

    APAC IUCD devices Market Segmentation:
    By Type: Overview
    By Country: Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia and Philippines
    Key Companies Profiled in the report: Bayer, Teva Pharmaceutical Industries Ltd, Allergen, DKT International, SMB Corporation, OCON Medical Ltd, Mona Lisa N.V., Medisafe Distribution

    Request For Sample @ https://www.researchcosmos.com/request/843566907

    The APAC intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.

    The APAC intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

    On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare.

    Make an Inquiry before buying @ https://www.researchcosmos.com/inquire/843566907

    About Us:
    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

older | 1 | .... | 1026 | 1027 | (Page 1028) | 1029 | 1030 | .... | 1118 | newer